ADVANTAGE INVESTMENT MANAGEMENT, LLC - THRESHOLD PHARMACEUTICAL INC ownership

THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 61 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ADVANTAGE INVESTMENT MANAGEMENT, LLC ownership history of THRESHOLD PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2017$0
-100.0%
1,0000.0%0.00%
Q1 2017$1,0001,0000.0%0.00%
Q4 2016$0
-100.0%
1,0000.0%0.00%
Q3 2016$1,0000.0%1,0000.0%0.00%
Q2 2016$1,0001,0000.0%0.00%
Q1 2016$01,0000.0%0.00%
Q4 2015$0
-100.0%
1,0000.0%0.00%
-100.0%
Q3 2015$4,0000.0%1,0000.0%0.00%0.0%
Q2 2015$4,0000.0%1,0000.0%0.00%0.0%
Q1 2015$4,000
+33.3%
1,0000.0%0.00%0.0%
Q4 2014$3,0001,0000.00%
Other shareholders
THRESHOLD PHARMACEUTICAL INC shareholders Q2 2016
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 393,000$1,556,0001.48%
FORTALEZA ASSET MANAGEMENT INC/ 98,125$389,0000.18%
Rhenman & Partners Asset Management AB 121,537$481,0000.14%
Baker Brothers Advisors 1,826,358$7,232,0000.09%
Rotella Capital Management, Inc. 21,600$86,0000.07%
SSI INVESTMENT MANAGEMENT LLC 117,640$466,0000.04%
FEDERATED HERMES, INC. 2,391,400$9,470,0000.03%
TFS CAPITAL LLC 96,659$383,0000.03%
SMITH ASSET MANAGEMENT GROUP LP 191,038$757,0000.03%
FRANKLIN STREET ADVISORS INC /NC 28,000$111,0000.02%
View complete list of THRESHOLD PHARMACEUTICAL INC shareholders